Serum Concentrations of Chemokines CCL20, CXCL8 and CXCL10 in Relapsing-Remitting Multiple Sclerosis and Their Association with Presence of Antibodies against Epstein–Barr Virus
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158064 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jelena Košćak Lukač und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Clinical Hospital "Sveti Duh", Sveti Duh 64, 10 000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Chemokine CXCL10, Herpesvirus 4, Human, Chemokine CCL20. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation, Antica and Croatian Science Foundation.
Abstract (Originalsprache)
Epstein–Barr virus (EBV) infection and various chemokines, including CCL20, CXCL8 and CXCL10 are considered to participate in the pathogenesis of multiple sclerosis (MS), and several studies point to a direct regulatory effect of EBV on the expression of these chemokines. In our study we hypothesized that serum concentrations of CCL20, CXCL8 and CXCL0 are induced in patients with relapsing-remitting MS (RRMS) in comparison to healthy individuals, and that they are associated with EBV infection. Serum concentrations of CXCL8 and CXCL10 were lower in RRMS patients in relapse in comparison to healthy controls. Although potential effects of corticosteroid therapy introduced in a subgroup of RRMS patients prior to sampling were excluded by subgroup comparison, this possibility has to be considered while interpreting the results. We found an inverse association between serum concentrations of CXCL8 and anti-Epstein–Barr Virus Nuclear Antigen (EBNA) IgG and decreased expression of CXCL8 in peripheral blood mononuclear cells (PBMC) in relapse compared to remission. Lower serum concentrations of CXCL8 and CXCL10 in RRMS patients and decreased peripheral production of CXCL8 in relapse may indicate compensatory anti-inflammatory counter-regulation in MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Clinical Hospital "Sveti Duh", Sveti Duh 64, 10 000 Zagreb, Croatia.
- Neurology Clinic, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Josipa Huttlera 4, 31 000 Osijek, Croatia.
- Laboratory for Molecular Immunology, Croatian Institute for Brain Research, Šalata 12, 10 000 Zagreb, Croatia.
- Department of Physiology and Immunology, University of Zagreb School of Medicine, Šalata 3, 10 000 Zagreb, Croatia.
- Department of Anesthesiology, Reanimatology, Intensive Medicine and Pain Therapy, University Hospital Centre Zagreb, Kišpatićeva 12, 10 000 Zagreb, Croatia.
- Department of Anatomy, University of Zagreb School of Medicine, Šalata 11, 10 000 Zagreb, Croatia.
ORCID-Profile: Alan Šućur
Förderung
- Croatian Science Foundation
- Antica and Croatian Science Foundation
Zitieren
APA
Košćak Lukač, J., Baronica, K. B., Šućur, A., Sremec, J., Tomasović, S., Baronica, R., Kelava, T., Grčević, D., & Kovačić, N. (2024). Serum Concentrations of Chemokines CCL20, CXCL8 and CXCL10 in Relapsing-Remitting Multiple Sclerosis and Their Association with Presence of Antibodies against Epstein–Barr Virus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158064
Vancouver
Košćak Lukač J, Baronica KB, Šućur A, Sremec J, Tomasović S, Baronica R, et al. Serum Concentrations of Chemokines CCL20, CXCL8 and CXCL10 in Relapsing-Remitting Multiple Sclerosis and Their Association with Presence of Antibodies against Epstein–Barr Virus. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158064
BibTeX
@article{KoakLuka2024,
author = {Košćak Lukač, Jelena and Baronica, Koraljka Bačić and Šućur, Alan and Sremec, Josip and Tomasović, Sanja and Baronica, Robert and Kelava, Tomislav and Grčević, Danka and Kovačić, Nataša},
title = {Serum Concentrations of Chemokines CCL20, CXCL8 and CXCL10 in Relapsing-Remitting Multiple Sclerosis and Their Association with Presence of Antibodies against Epstein–Barr Virus},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158064}
}
EUVIMED